In this episode, we’re going DEEP on what’s broken in primary care and what it actually takes to fix it – not with another point solution, but with an AI-first care delivery platform.
Dr. David Carmouche, Chief Medical and Commercial Officer at Lumeris, has a resume that reads like a masterclass in healthcare transformation: practicing PCP → Blue Cross Louisiana CMO → Ochsner VP of Primary Care & VBC → Head of Walmart Health → now Lumeris. He’s seen every angle of the primary care crisis firsthand, and he’s not sugarcoating it.
We got into the real reason Walmart Health shut down, why Ochsner just went all-in on Lumeris’s AI agent “Tom,” and David’s provocative white paper arguing a single PCP could manage 5,000 patients with the right AI stack.
Listen to hear why:
-The ROI case for AI-enabled primary care is almost embarrassingly simple once you model it as a front door strategy, not a cost center.
-Health systems face two internal sales: a fast one with the C-suite and a slow one with clinicians. Confusing the two kills deals.
-The in-office primary care visit is the exception, not the rule, in 10 years. David lays out what replaces it.
-First movers who crack AI-enabled primary care access don’t just improve outcomes; they structurally take market share from competitors who don’t.
Tom™ is the agentic AI that delivers orchestrated Primary Care as a Service, expanding care capacity and patient engagement while reducing clinicians’ busy workloads. Tom serves as the AI member of a patient’s primary care team.
Lumeris: https://www.lumeris.com
Follow Dr. David Carmouche on LinkedIn: https://www.linkedin.com/in/david-carmouche-md/
Follow Blake on LinkedIn: https://www.linkedin.com/in/blakecmadden/
For expert analysis on healthcare M&A, strategy, finance, and markets, join 51K+ readers of Blake Madden’s Hospitalogy newsletter. Subscribe here: https://hospitalogy.com/
Like our episodes? Be sure to leave us a review, and share our podcast with colleagues.